On Cupcakes and HIPAA
Do certain pharmaceutical physician marketing practices violate HIPAA -- the Health Insurance Portability and Accountability Act -- specifically, the patient privacy regulations under that...
Is Big Pharma Shifty?
The allegations against Avandia have re-ignited the criticisms of pharmaceutical marketing. An Adweek article claimed that a recent poll conducted by Harris Interactive for...
Avandia: Enough Blame to Go Around
Whenever a widely promoted and blockbuster Rx drug is found to adversely affect some patients, many people focus all or most of the blame...
GSK May “Step Into the [DTC] Void” to Defend Avandia
According to a Wall Street Journal article, a Glaxo spokeswoman said the company isn't planning consumer ads defending Avandia, but won't rule them out,...
Dumb Blonde Reps vs. Slovenly Genius Reps
Ed Silverman over at Pharmalot posted a fun little item about a poll that Cafe Pharma is currently running.Ed asked "Do Good-Looking Reps Do...
Podcast Today! Mack vs. Ehrlich/Blogs vs. DTC
Listen to a FREE! live podcast today at 1 PM Eastern Time!Blogs vs. DTC: What's Best for Consumers?Exploring Blogs as a Counter to Other...
Temple vs. Nissen: Blood Rematch
Bob Temple, director of the Office of Medical Policy at FDA, admits that "some of the withering criticism of the agency is getting under...
Alli Ad Campaign Promises Honesty, But Does It Deliver?
Do you have a "extra pair of pants" with you today! GSK recommends you do when starting a regimen of its over-the-counter diet pill...
Advice to GSK on Handling the Avandia Avalanche: Don’t Do What Merck Did
Dear GSK,Already the press is making strong analogies between Avandia and Vioxx (see "Sequel for Vioxx Critic: Attack on Avandia"). But if you are...
Podcast::The Importance of Downstream Channel Sales Data for Marketing
---Sponsored Notice---Do you know what you sold yesterday? Could you use more timely data to improve the success of marketing campaigns and...
